1. Home
  2. STEC vs ESLA Comparison

STEC vs ESLA Comparison

Compare STEC & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STEC
  • ESLA
  • Stock Information
  • Founded
  • STEC 2006
  • ESLA 2021
  • Country
  • STEC Hong Kong
  • ESLA United States
  • Employees
  • STEC N/A
  • ESLA N/A
  • Industry
  • STEC
  • ESLA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STEC
  • ESLA Health Care
  • Exchange
  • STEC NYSE
  • ESLA Nasdaq
  • Market Cap
  • STEC 29.7M
  • ESLA 35.5M
  • IPO Year
  • STEC 2021
  • ESLA N/A
  • Fundamental
  • Price
  • STEC $0.89
  • ESLA $0.91
  • Analyst Decision
  • STEC
  • ESLA Strong Buy
  • Analyst Count
  • STEC 0
  • ESLA 1
  • Target Price
  • STEC N/A
  • ESLA $16.00
  • AVG Volume (30 Days)
  • STEC 16.3K
  • ESLA 521.7K
  • Earning Date
  • STEC 07-07-2025
  • ESLA 08-20-2025
  • Dividend Yield
  • STEC N/A
  • ESLA N/A
  • EPS Growth
  • STEC N/A
  • ESLA N/A
  • EPS
  • STEC N/A
  • ESLA N/A
  • Revenue
  • STEC $10,672,000.00
  • ESLA N/A
  • Revenue This Year
  • STEC $9,392.20
  • ESLA $101.09
  • Revenue Next Year
  • STEC N/A
  • ESLA N/A
  • P/E Ratio
  • STEC N/A
  • ESLA N/A
  • Revenue Growth
  • STEC N/A
  • ESLA N/A
  • 52 Week Low
  • STEC $0.20
  • ESLA $0.63
  • 52 Week High
  • STEC $3.25
  • ESLA $3.23
  • Technical
  • Relative Strength Index (RSI)
  • STEC 44.88
  • ESLA 49.49
  • Support Level
  • STEC $0.76
  • ESLA $0.89
  • Resistance Level
  • STEC $1.00
  • ESLA $1.02
  • Average True Range (ATR)
  • STEC 0.10
  • ESLA 0.08
  • MACD
  • STEC -0.01
  • ESLA -0.00
  • Stochastic Oscillator
  • STEC 32.25
  • ESLA 45.00

About STEC SANTECH HOLDINGS LIMITED

Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: